EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 68 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,655,208 | -9.4% | 207,160 | -1.3% | 0.27% | +5.9% |
| Q2 2023 | $1,826,556 | +163.5% | 209,949 | -11.0% | 0.26% | +152.5% |
| Q1 2023 | $693,181 | +98084.3% | 235,776 | +16.8% | 0.10% | -8.2% |
| Q4 2022 | $706 | -100.0% | 201,810 | -41.0% | 0.11% | -74.5% |
| Q3 2022 | $2,705,000 | +22.8% | 341,974 | +22.2% | 0.43% | +21.3% |
| Q2 2022 | $2,202,000 | -34.5% | 279,850 | +1.2% | 0.36% | -15.0% |
| Q1 2022 | $3,361,000 | +22.4% | 276,591 | +23.4% | 0.42% | +33.4% |
| Q4 2021 | $2,745,000 | +52.7% | 224,229 | +30.0% | 0.31% | +42.1% |
| Q3 2021 | $1,798,000 | – | 172,527 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |